Pierre is an experienced biotech entrepreneur and former investment banker with extensive multidisciplinary experience spanning the entire product lifecycle of highly innovative life sciences technologies. His expertise encompasses roles as a founder, inventor, operator, and advisor, building and guiding innovations from concept through development to market maturity, securing equity and debt financing, and contributing to successful exits.
At Mursla Bio, he
Before this, Pierre gained a decade of experience in healthcare investment banking at J.P. Morgan, where he was involved in closing over 20 deals totaling $70 billion. This includes several M&A divestments such as Siemens Healthcare assets, M&A buy-side transactions such as Sanofi / BMP Sunstone and Zentiva / Eczacıbaşı, equity and debt acquisition financing transactions such as Roche / Genentech and Danone / WhiteWave and IPOs. In addition to deal-making, Pierre was entrusted with managing over 40 analysts and associates across the EMEA region, serving as a resource manager and leadership figure. He further distinguished himself by becoming the first J.P. Morgan representative sent to Japan to support global M&A initiatives in the region. His contributions earned him recognition by eFinancialCareers as one of the most impressive Vice Presidents in investment banking.
He earned a Master in Management from the leading European business institution HEC Paris (Grande École). Previously, he completed a classe préparatoire programme specializing in mathematics at Saint-Jean de Douai, which is equivalent to the undergraduate level.